CGT Catapult has joined a new consortium - led by UK ATMP developer Achilles Therapeutics and which includes Leibniz University Hannover (Hannover) as project coordinator and the Fundacion para la Investigacion del Hospital Universitario la Fe de la Comunidad Valenciana (Valencia) – with the goal of developing a smart bioprocessing manufacturing platform (bioreactor) for personalised cell therapies. Click to read more.
London, 22 July 2022 – Cell and Gene Therapy Catapult (CGT Catapult) today announced the launch of a new consortium that will drive forward innovation and advancement in the manufacturing of personalised cell therapies. The new consortium – led by UK ATMP developer Achilles Therapeutics and which al.
Achilles Therapeutics PLC: Achilles Therapeutics to lead Horizon Europe-Funded Consortium to Advance Personalized Cell Therapy Manufacturing finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.